SCHEMBL4617645

SCHEMBL4617645

CCc1ccc(S(=O)(=O)c2ccc(F)cc2)cc1S(=O)(=O)NC(C)C(O)c1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SFRP1 Q8N474 3/20 0.46
ALOX5AP P20292 1/20 0.42
FEN1 P39748 1/20 0.42
HTR2A P28223 3/20 0.40
HTR2C P28335 3/20 0.40
KCNH2 Q12809 2/20 0.40
ALDH1A1 P00352 2/20 0.40
KDM4E B2RXH2 1/20 0.40
GMNN O75496 1/20 0.40
LMNA P02545 1/20 0.40
POLB P06746 1/20 0.40
MAPT P10636 1/20 0.40
HPGD P15428 1/20 0.40
PMP22 Q01453 1/20 0.40
KMT2A Q03164 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
METAP2 P50579 3/20 0.37
CYP2D6 P10635 1/20 0.37
MMP1 P03956 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6104352 0.87 ALDH1A1 (0.50) SFRP1ALOX5APFEN1HTR2AHTR2C
SCHEMBL4637256 0.82 SFRP1 (0.52) SFRP1ALOX5APFEN1HTR2AHTR2C
SCHEMBL6101274 0.80 ALDH1A1 (0.54) SFRP1ALOX5APFEN1HTR2AALDH1A1
SCHEMBL6104199 0.79 ALDH1A1 (0.45) ALOX5APFEN1ALDH1A1KDM4EGMNN
SCHEMBL6104202 0.79 ALDH1A1 (0.45) ALOX5APFEN1ALDH1A1KDM4EGMNN
SCHEMBL6101190 0.78 SFRP1 (0.51) SFRP1
SCHEMBL6100969 0.78 SFRP1 (0.51) SFRP1
SCHEMBL6100961 0.78 SFRP1 (0.51) SFRP1
SCHEMBL6102529 0.78 SFRP1 (0.51) SFRP1
SCHEMBL6102534 0.78 SFRP1 (0.51) SFRP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1879859-A2 DIARYLSULFONE SULFONAMIDES AND USE THEROF Wyeth a Corporation of the State of Delaware (US) 2008-01-23 EP claimed
US-20060276464-A1 Diarylsulfone sulfonamides and use thereof WYETH (US) 2006-12-07 US claimed
WO-2006124875-A2 DIARYLSULFONE SULFONAMIDES AND USE THEROF WYETH (US) 2006-11-23 WO claimed
EP-1879859-A2 DIARYLSULFONE SULFONAMIDES AND USE THEROF Wyeth a Corporation of the State of Delaware (US) 2008-01-23 EP disclosed
US-20060276464-A1 Diarylsulfone sulfonamides and use thereof WYETH (US) 2006-12-07 US disclosed
WO-2006124875-A2 DIARYLSULFONE SULFONAMIDES AND USE THEROF WYETH (US) 2006-11-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060276464-A1 Diarylsulfone sulfonamides and use thereof SFRP1, SOS1, FZD7 SFRP1 1/4885ALOX5AP 3153/4885FEN1 4380/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.